Writing about Literature in the Digital Age

There's a division of Eli Lilly called e.Lilly, which has been experimenting with using internal stock markets and hypothetical drug candidates to predict whether new drugs will gain FDA approval. That's an essential thing for drug companies to know, because their whole business depends on them not only picking winners—that is, good, safe drugs—but also killing losers before they've invested too much money in them.

But he contends that it's not necessarily the lack of demographic diversity that's at the heart of the problems... it's cognitive diversity you need. If those doing the hiring are going after only world-class, exceptionally bright people with similar skills, the differences between the Chosen Ones may not be that useful. He claims the company needs to hire not just only the smartest people!